Effect of vitamin B12 and folic acid supplementation on biomarkers of endothelial function and inflammation among elderly individuals with hyperhomocysteinemia

Effects of 2-year vitamin B12 and folic acid supplementation in hyperhomocysteinemic elderly on arterial stiffness and cardiovascular outcomes within the B-PROOF trial

(2015) Suzanne C. van Dijk et al.   JOURNAL OF HYPERTENSION

Effect of daily vitamin B-12 and folic acid supplementation on fracture incidence in elderly individuals with an elevated plasma homocysteine concentration: B-PROOF, a randomized controlled trial

(2014) Janneke P van Wijngaarden et al.   AMERICAN JOURNAL OF CLINICAL NUTRITION

Vitamin B supplementation, homocysteine levels, and the risk of cerebrovascular disease: A meta-analysis

(2013) Y. Ji et al.   NEUROLOGY

Meta-analysis of B vitamin supplementation on plasma homocysteine, cardiovascular and all-cause mortality

(2012) Tao Huang et al.   CLINICAL NUTRITION

Rationale and design of the B-PROOF study, a randomized controlled trial on the effect of supplemental intake of vitamin B12and folic acid on fracture incidence

(2011) Janneke P van Wijngaarden et al.   BMC Geriatrics

Effects of Lowering Homocysteine Levels With B Vitamins on Cardiovascular Disease, Cancer, and Cause-Specific MortalityMeta-analysis of 8 Randomized Trials Involving 37 485 IndividualsEffects of Lowering Homocysteine Levels

(2010)   ARCHIVES OF INTERNAL MEDICINE

The homocysteine controversy

(2010) Yvo M. Smulders et al.   JOURNAL OF INHERITED METABOLIC DISEASE

Effect of Long-Term Homocysteine Reduction with B Vitamins on Arterial Wall Inflammation Assessed by Fluorodeoxyglucose Positron Emission Tomography: A Randomised Double-Blind, Placebo-Controlled Trial

(2009) Kathleen Potter et al.   CEREBROVASCULAR DISEASES

Homocysteine modulates the proteolytic potential of human arterial smooth muscle cells through a reactive oxygen species dependant mechanism

(2009) Xue Dan Ke et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

Prospective association of vascular endothelial growth factor-A (VEGF-A) with coronary heart disease mortality in Southeastern New England

(2008) Charles B. Eaton et al.   ATHEROSCLEROSIS